{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:03:50Z","timestamp":1768287830989,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00399-018-0600-0","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T16:49:49Z","timestamp":1540486189000},"page":"369-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Kardiale Kontraktilit\u00e4tsmodulation zur Behandlung der chronischen Herzinsuffizienz","Cardiac contractility modulation for treatment of chronic heart failure"],"prefix":"10.1007","volume":"29","author":[{"given":"J.","family":"Kuschyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rudic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Liebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"T\u00fcl\u00fcmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Borggrefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"issue":"10","key":"600_CR1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","volume":"6","author":"WT Abraham","year":"2018","unstructured":"Abraham WT, Kuck KH, Goldsmith RL et\u00a0al (2018) A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. Jacc Heart Fail 6(10):874. https:\/\/doi.org\/10.1016\/j.jchf.2018.04.010","journal-title":"Jacc Heart Fail"},{"key":"600_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cardfail.2011.05.006","volume":"17","author":"WT Abraham","year":"2011","unstructured":"Abraham WT, Nademanee K, Volosin K et\u00a0al (2011) Subgroup analysis of a\u00a0randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J\u00a0Card Fail 17:710\u2013717","journal-title":"J Card Fail"},{"key":"600_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/eurheartj\/ehn020","volume":"29","author":"MM Borggrefe","year":"2008","unstructured":"Borggrefe MM, Lawo T, Butter C et al (2008) Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart\u00a0J 29:1019\u20131028","journal-title":"Eur Heart J"},{"key":"600_CR4","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jacc.2008.01.036","volume":"51","author":"C Butter","year":"2008","unstructured":"Butter C, Rastogi S, Minden HH et\u00a0al (2008) Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J\u00a0Am Coll Cardiol 51:1784\u20131789","journal-title":"J Am Coll Cardiol"},{"key":"600_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cardfail.2006.11.004","volume":"13","author":"C Butter","year":"2007","unstructured":"Butter C, Wellnhofer E, Schlegl M et\u00a0al (2007) Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption. J\u00a0Card Fail 13:137\u2013142","journal-title":"J Card Fail"},{"key":"600_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00259-011-1977-8","volume":"39","author":"G Goliasch","year":"2012","unstructured":"Goliasch G, Khorsand A, Schutz M et al (2012) The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure. Eur J Nucl Med Mol Imaging 39:408\u2013415","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"600_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ahj.2010.10.025","volume":"161","author":"A Kadish","year":"2011","unstructured":"Kadish A, Nademanee K, Volosin K et al (2011) A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart\u00a0J 161:329\u2013337.e1-2","journal-title":"Am Heart J"},{"key":"600_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijcard.2016.02.001","volume":"209","author":"A Kloppe","year":"2016","unstructured":"Kloppe A, Lawo T, Mijic D et al (2016) Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration. Int J Cardiol 209:291\u2013295","journal-title":"Int J Cardiol"},{"key":"600_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5603\/CJ.a2015.0073","volume":"23","author":"A Kloppe","year":"2016","unstructured":"Kloppe A, Mijic D, Schiedat F et\u00a0al (2016) A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: a preliminary report. Cardiol\u00a0J 23:114\u2013119","journal-title":"Cardiol J"},{"key":"600_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/europace\/eut311","volume":"16","author":"KH Kuck","year":"2014","unstructured":"Kuck KH, Bordachar P, Borggrefe M et\u00a0al (2014) New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. Europace 16:109\u2013128","journal-title":"Europace"},{"key":"600_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3909\/ricm0825","volume":"18","author":"J Kuschyk","year":"2017","unstructured":"Kuschyk J, Kloppe A, Schmidt-Schweda S et al (2017) Cardiac contractility modulation: a technical guide for device implantation. Rev Cardiovasc Med 18:1\u201313","journal-title":"Rev Cardiovasc Med"},{"key":"600_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijcard.2014.12.178","volume":"183","author":"J Kuschyk","year":"2015","unstructured":"Kuschyk J, Roeger S, Schneider R et al (2015) Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients. Int J Cardiol 183:76\u201381","journal-title":"Int J Cardiol"},{"key":"600_CR13","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.hrthm.2015.06.022","volume":"12","author":"J Kuschyk","year":"2015","unstructured":"Kuschyk J, Stach K, Tulumen E et al (2015) Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices. Heart Rhythm 12:2230\u20132238","journal-title":"Heart Rhythm"},{"key":"600_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","volume":"93","author":"A Mosterd","year":"2007","unstructured":"Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93:1137\u20131146","journal-title":"Heart"},{"key":"600_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cardfail.2009.08.009","volume":"16","author":"J Myers","year":"2010","unstructured":"Myers J, Goldsmith RL, Keteyian SJ et\u00a0al (2010) The ventilatory anaerobic threshold in heart failure: a\u00a0multicenter evaluation of reliability. J\u00a0Card Fail 16:76\u201383","journal-title":"J Card Fail"},{"key":"600_CR16","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et\u00a0al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart\u00a0J 37:2129\u20132200","journal-title":"Eur Heart J"},{"key":"600_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/clc.22919","volume":"41","author":"S Roger","year":"2018","unstructured":"Roger S, Rudic B, Akin I et al (2018) Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction. Clin Cardiol 41:518\u2013524","journal-title":"Clin Cardiol"},{"key":"600_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jjcc.2016.06.015","volume":"69","author":"S Roger","year":"2017","unstructured":"Roger S, Said S, Kloppe A et\u00a0al (2017) Cardiac contractility modulation in heart failure patients: randomized comparison of signal delivery through one vs. two ventricular leads. J\u00a0Cardiol 69:326\u2013332","journal-title":"J Cardiol"},{"key":"600_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/europace\/euu050","volume":"16","author":"S Roger","year":"2014","unstructured":"Roger S, Schneider R, Rudic B et\u00a0al (2014) Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation. Europace 16:1205\u20131209","journal-title":"Europace"},{"key":"600_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1609758","volume":"377","author":"L Shen","year":"2017","unstructured":"Shen L, Jhund PS, Petrie MC et\u00a0al (2017) Declining risk of sudden death in heart failure. N\u00a0Engl J Med 377:41\u201351","journal-title":"N Engl J Med"},{"key":"600_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jcmg.2009.07.011","volume":"2","author":"CM Yu","year":"2009","unstructured":"Yu CM, Chan JY, Zhang Q et\u00a0al (2009) Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. JACC Cardiovasc Imaging 2:1341\u20131349","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-018-0600-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-018-0600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-018-0600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T17:23:36Z","timestamp":1662312216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-018-0600-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1007\/s00399-018-0600-0","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Kuschyk und M.\u00a0Borggrefe geben folgenden Interessenkonflitk an: Beratert\u00e4tigkeit, Vortragshonorare und Reisekosten\u00fcbernahme von Impulse Dynamics und Boston Scientific. B.\u00a0Rudic gibt folgenden Interessenkonflikt an: Vortragshonorare und Reisekosten\u00fcbernahme von Impulse Dynamics und Boston Scientific. V.\u00a0Liebe, E.\u00a0T\u00fcl\u00fcmen und I.\u00a0Akin geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Die Autoren versichern, dass die in der \u00dcbersicht genannten Untersuchungen mit Zustimmung der jeweils zust\u00e4ndigen Ethik-Kommission erfolgten, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}